Two mentions and one article in three publications during end of November

News The results from the NEFERTITI-study have received much attention since they were first published in a press release from October 11th. During the last week of November, there were no less than three publications that mentioned Gedea and were spread through e.g., Twitter and LinkedIn. First…


Gedea Biotech AB
Medicon Village
Scheeletorget 1
223 81 Lund
Sweden

Annette Säfholm, CEO
annette.safholm@gedeabiotech.com
+46 (0) 708 – 91 86 81